Posts Tagged ‘Scientists’

Science Officers Lead The Way

Friday, March 12th, 2010
Chief Science Officers come from a variety of Science backrounds including Pharmacy

Chief Science Officers come from a variety of Science backrounds including Pharmacy

Science Officers Lead The Way in Irelands start up and established Pharmaceutical R&D companies. They provide the scientific backbone of R&D, Regulatory affairs and Pharmacovigilence activity where insight and understanding go hand in hand.

A typical Chief Science Officer will  manage and administer the actvities of other medical drug safety officers, science officers and technical personnel involved first hand in project engineering and the management of  other scientists who may also be Pharmacists engaged in the introduction of new drugs which will also involve vigilence reporting and monitoring of ADR’s and PSUR’s.

Irish Pharmaceutical enterprises are highly engaged in the latest Pharmaceutical drug research and development and it is through the technical and scientific know how of science officers that Ireland has gained significant FDI (Foreign Direct  Investment)

Eight out of ten major internationla biopharma and pharmaceutical multinationals have now sited here in Ireland and this is showing no sign of slowing yet despite the economic downturn.

Science Jobs are Engineering the Future

Thursday, January 7th, 2010
Science Jobs in Engineering

Science Jobs in Engineering

Science Jobs are engineering the future in Ireland today as the demand for R&D Engineers, Polymer Engineers, QA/RA Engineers and openings for senior professionals such as, Head of Research & Development,  Regulatory Affairs Specialists and Scientists continues to increase despite the economic downturn.

In particuar Research and Development investment from inward and outward sources has trebled in the past 10 years and is now at €2.6 billion or almost 1.7% of GNP. Intelectual property rights within the pharmaceutical, medical devices, software and ICT  manufacturing industries are now being given serious consideration as a major and strategic contributor to Ireland’s economy which as a revenue generator has a far greater long term financial generational potential than energy resource such as offshore oil and gas which todate have proved so far to be both costly and disappointing.

With the advent of the internet, Ireland has found its engineers and scientists research and design skills are now open for trade with the world and unlike natural resources are only limited by the numbers we educate and train in our universities and colleges.

To this end, Ireland has already begun a move away from depending on the goodwill or self interest of overseas multinationals and is now making provision for the future itself by strategically identifying those industries and markets worldwide that our native human resource skills can be applied to and to gain our financial share of  a global market that numbers in the Trillions of Euros.

As previously mentioned Ireland is already at an advanced stage of exploiting opportunities within the global nano technology markets that combine hybrid technolgies such as biopharma -nanobots, programable drugs and micro medical devices.

Instead of being discouraged by the limitations of what resources we have had in the past, Ireland is now positively assessing what we do have and the futher potential we have by shaping the world around us to our advantage to engineer the future.

After all  the description of Ireland in the past as that as the Island of Saints and Scholars is not far from what we would wish overseas investors seeing Ireland anew as, the Isle of R&D.

Killing Leukaemeia

Monday, November 2nd, 2009
3- 5 years from Killing Cancer

3- 5 years from Killing Cancer

Killing Leukaemia has been the objective of  Cancer Research Scientists for decades. Today that objective has come a step closer with the announcement in the international journal, Cancer Research , that TCD in partnership with the University of Sienna have discovered a new drug called PBOX-15 capable of killing cancerous cells in adult patients with poor prognosis.

R&D is still at an early stage however with development of a viable drug between 3- 5 years from being produced according to Professor Mark Lawlor of TCD’S school of medicine. The study itself involved research across the disciplines of molecular, chemistry and biochemistry at TCD together with contributions from Research colleagues in Belfast City Hospital, Siennna and St James Hospital Dublin.

R&D continues to witness increasing growth despite the downturn

Thursday, October 22nd, 2009
Research and Development in Biotechnology

Research and Development in Biotechnology

R&D continues to witness increasing growth despite the  downturn taking place in Ireland as new announcements have continued to be made by multinational companies involved in areas such as Medical Devices, Biopharma and Pharmaceutical manufacturing.

R&D or Research and Development has resulted in greater career prospects at home for Irelands science and technical professionals who continue to gain international respect for their work in fields as diverse as polymer technology, advanced medical products, telecommunications software and hardware.

As a result there has been a major increase in demand for R&D managers, R&D Engineers and Research associates carrying out front line research which has had the spin off effect of an increase in demand for Quality Assurance Managers and Engineers in addition to Regulatory Affairs professionals who form part of the collective support structure required for this ever increasing technical environment.

Recruitment is brisk and demand for science professionals for all these sectors is steadily increasing at a pace that seems to defy the current economic trend. Long may it continue